Osteoarthritis
Conditions
Interventions
Group A:Posterior joint capsule injection: A single intraoperative dose of Bupivacaine Liposome Injection (4 mg/kg, maximum 266 mg) was administered for local infiltrative anesthesia around the knee j
Group B:No posterior joint capsule injection: A single intraoperative dose of Bupivacaine Liposome Injection (4 mg/kg, maximum 266 mg) was administered for local infiltrative anesthesia around the kne
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Intending to schedule a TKA; 2. Age>= 60 years old; 3. Fully understand the benefits and risks of this study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Complies with the contraindications of this medication; 2. Previous allergy to amide local anesthetics; Abnormal liver and kidney function; 3. Suffering from heart disease; 4. Refusing to participate in this study due to reasons such as mental illness and inability to communicate with researchers, understand the risks and benefits.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS scores; | — |
Secondary
| Measure | Time frame |
|---|---|
| Knee joint range of motion; | — |
Countries
China
Contacts
Public ContactSi Haibo
West China Hospital of Sichuan University
Outcome results
None listed